Notice to Exel Composites Plc’s Annual General Meeting 2026

Exel Composites has called its Annual General Meeting for 26 March 2026 where the Board proposes no dividend for FY2025 and seeks shareholder approval for governance and capital measures including re-election of several directors, re-election of auditor Ernst & Young Oy, and approval of the Remuneration Report. The Board requests authorizations to repurchase up to 5,250,000 shares (~5% of shares) and to issue up to 10,500,000 new shares (~10%), and proposes a 15-for-1 reverse share split with related directed share issue (up to 150,000 treasury shares) and redemption to eliminate fractions; current total shares are 106,728,395 with 1,167,527 treasury shares. The AGM notice also sets board compensation levels, makes the sustainability assurer appointment conditional on applicable legislation, and limits authorizations to the next AGM or specified cut-off dates (buyback and issue authorizations until no later than 30 June 2027).

Analysis

Market structure: The AGM package is a mix of technical fixes (15:1 reverse split), optional liquidity tools (buyback authorization up to ~5% = 5.25M shares) and a large issuance headroom (up to ~10% = 10.5M shares). Short-term winners are management and potential acquirers who get flexibility to use equity as consideration; losers are unprotected minority holders facing up to 10% dilution if the board issues shares. The reverse split (resulting share count ~7.12M from 106.7M) is a clear attempt to lift per-share price to attract institutional/retail demand and reduce microcap trading friction.

Risk assessment: Tail risks include a directed equity raise that dilutes >8–10% within 3–6 months, or a reverse split signaling thin liquidity and eventual delisting/M&A; probability medium but impact high. Immediate (days) risks: trading interruptions around Reverse Split Date; short-term (weeks–months): share issuance or directed deals; long-term (quarters): execution risk in wind/transport markets and potential sustainability reporting cost changes. Watch hidden dependencies: board will buy shares for compensation within two weeks after the Q1 business review — that timing reveals signal (support vs. cash conservation).

Trade implications: Direct play — tactical long EXEL.HE ahead of technical rerating from the reverse split sized 1–3% of portfolio, stop -15%, target +30% in 6–12 months if no dilutive issuance announced. Defensive hedge — buy 3–6 month put spreads (buy 20–30% OTM put, sell 10–15% OTM put) sized to cap downside to ~10–12% cost. Relative value — pair long EXEL.HE vs short OMXHPI (or a Finnish industrial ETF) to isolate company-specific rerating; reweight after Q1 review and any issuance/M&A disclosures.

Contrarian angle: Consensus treats the reverse split as cosmetic; it may presage an opportunistic acquisition financed by non-pro rata equity which can be value-accretive if deployed into bolt-on technology or ruinous if used for working capital. Historical parallel: small-cap reverse splits often precede M&A or equity raises within 6–9 months; therefore treat any absence of buyback/buy-ins in the 30–90 day window as negative. Immediate catalysts to watch: Q1 Business Review publication date, actual board share purchases (within two weeks thereafter), and any directed share issue notices — trade decisions should pivot on these events.

Key Decisions for Investors

• Establish a tactical long position in Exel Composites (EXEL.HE) sized 1–3% of fund NAV before the announced Reverse Split Date to capture a technical rerating; set a hard stop-loss at -15% and profit target +30% within 6–12 months, and trim if a directed share issue is announced.
• Purchase a 3–6 month put spread as downside protection: buy 20–30% OTM puts and sell 10–15% OTM puts (size to cap portfolio-level loss to ~10–12%) to hedge tail risk from potential >8% dilution or adverse M&A financing.
• Enter a pair trade: long EXEL.HE vs short OMXHPI (or a Finnish industrial ETF) equal dollar notional to isolate company-specific upside from technical rerating; reassess after Q1 Business Review or any share-issue announcement within 30–90 days.
• Do not add exposure beyond pilot size until two specific signals occur: (A) confirmation of board buybacks (shares acquired within two weeks after Q1 Business Review) or (B) clear M&A use-case disclosed for share issuance; if neither occurs within 90 days, reduce exposure by 50%.
• Monitor the sustainability reporting legal update and the Q1 Business Review timing closely — if sustainability reporting obligations are removed (possible within 60 days), downgrade thesis due to lower transparency and potential governance risk; treat that as a sell/hedge trigger.